| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA665916 | B | Compound was measured for the inhibitory activity against Cytosolic phospholipase A 2 (c-PLA2) at 30 uM concentration | 1 | single protein format | Scientific Literature | |||
| 2. | ALA665917 | B | Compound was measured for the inhibitory activity against Cytosolic phospholipase A2 (c-PLA2) | 1 | single protein format | Scientific Literature | |||
| 3. | ALA665918 | B | Compound was measured for the inhibitory activity against Cytosolic phospholipase A2 (c-PLA2) at 100 uM concentration | 1 | single protein format | Scientific Literature | |||
| 4. | ALA665919 | B | Compound was measured for the inhibitory activity against Cytosolic phospholipase A2 (c-PLA2); not determined | 3 | single protein format | Scientific Literature | |||
| 5. | ALA665921 | B | Inhibitory concentration against cystolic phospholipase A2 alpha receptor (c-PLA2 alpha) using coumarin assay | 4 | single protein format | Scientific Literature | |||
| 6. | ALA665294 | B | In vitro inhibition of cystolic phospholipase A2 alpha. | 17 | single protein format | Scientific Literature | |||
| 7. | ALA665295 | B | Inhibitory concentration against cystolic phospholipase A2 alpha receptor (c-PLA2 alpha) using coumarin assay | 1 | single protein format | Scientific Literature | |||
| 8. | ALA685237 | B | Inhibitory activity against human Group IVA Phospholipase A2 (GIVA PLA2); Inactive | 4 | single protein format | Scientific Literature | |||
| 9. | ALA685238 | B | Inhibitory activity against human Group IVA Phospholipase A2 (GIVA PLA2) | 3 | single protein format | Scientific Literature | |||
| 10. | ALA685239 | B | Inhibitory activity against human Group IVA Phospholipase A2 (GIVA PLA2), at 0.02 M | 1 | single protein format | Scientific Literature | |||
| 11. | ALA685240 | B | Percent inhibition of human GIVA PLA2 by the compound at a concentration (mole fraction) of 0.01 | 7 | single protein format | Scientific Literature | |||
| 12. | ALA685241 | B | Percent inhibition of human GIVA PLA2 by the compound at a concentration (mole fraction) of 0.02 | 1 | single protein format | Scientific Literature | |||
| 13. | ALA685242 | B | Percent inhibition of human GIVA PLA2 by the compound at a concentration (mole fraction) of 0.05 | 2 | single protein format | Scientific Literature | |||
| 14. | ALA685243 | B | Percent inhibition of human GIVA PLA2 by the compound at a concentration (mole fraction) of 0.08 | 2 | single protein format | Scientific Literature | |||
| 15. | ALA686432 | B | Mole fraction of compound in the total substrate interface required to inhibit human GIVA PLA2 by 50% | 10 | single protein format | Scientific Literature | |||
| 16. | ALA686433 | B | Inhibitory mole fraction against human GIVA PLA2 %; ND-not determined | Homo sapiens | 12 | single protein format | Scientific Literature | ||
| 17. | ALA856176 | B | Compound was measured for the inhibition of human platelet PLA2 (HP-PLA2) | 8 | assay format | Scientific Literature | |||
| 18. | ALA689329 | B | Compound was measured for the inhibition of human platelet PLA2 (HP-PLA2); No data | 3 | assay format | Scientific Literature | |||
| 19. | ALA689330 | B | Tested for the percentage inhibition of human platelet PLA2 (HP-PLA2) at concentration of 100 uM | 10 | assay format | Scientific Literature | |||
| 20. | ALA689331 | B | Tested for the percentage inhibition of human platelet PLA2 (HP-PLA2) at concentration of at 10 uM | 10 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!